Young & Partners Forum Series: How to Build an Effective Salesforce – Adam Woodrow of Paratek Pharmaceuticals
Adam Woodrow, President and Chief Commercial Officer, Paratek Pharmaceuticals Peter Young, President and CEO, Young & Partners
Young & Partners Forum Series: Drug Innovation Insights – Lessons From History – William Pao of Revelio Therapeutics
William Pao, CEO of Revelio Therapeutics and Former Chief Development Officer and Executive Vice President for Pfizer Peter Young, President and CEO, Young & Partners
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.
Young & Partners Forum Series: How to Build an Effective Salesforce – Adam Woodrow of Paratek Pharmaceuticals
Adam Woodrow, President and Chief Commercial Officer, Paratek Pharmaceuticals Peter Young, President and CEO, Young & Partners
Young & Partners Forum Series: Drug Innovation Insights – Lessons From History – William Pao of Revelio Therapeutics
William Pao, CEO of Revelio Therapeutics and Former Chief Development Officer and Executive Vice President for Pfizer Peter Young, President and CEO, Young & Partners
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.
Young & Partners Forum Series: How to Build an Effective Salesforce – Adam Woodrow of Paratek Pharmaceuticals
Adam Woodrow, President and Chief Commercial Officer, Paratek Pharmaceuticals Peter Young, President and CEO, Young & Partners
Young & Partners Forum Series: Drug Innovation Insights – Lessons From History – William Pao of Revelio Therapeutics
William Pao, CEO of Revelio Therapeutics and Former Chief Development Officer and Executive Vice President for Pfizer Peter Young, President and CEO, Young & Partners
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.
Young & Partners Forum Series: How to Build an Effective Salesforce – Adam Woodrow of Paratek Pharmaceuticals
Adam Woodrow, President and Chief Commercial Officer, Paratek Pharmaceuticals Peter Young, President and CEO, Young & Partners
Young & Partners Forum Series: Drug Innovation Insights – Lessons From History – William Pao of Revelio Therapeutics
William Pao, CEO of Revelio Therapeutics and Former Chief Development Officer and Executive Vice President for Pfizer Peter Young, President and CEO, Young & Partners
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.